Digital Health Startups

Interpace Biosciences provides molecular diagnostic tests for the early diagnosis and treatment of cancer, with a focus on risk-stratifying indeterminate thyroid nodules through genetic and mutational analysis. The company serves specialty physicians and medical centers in the U.S. and internationally.

1 investor

Interwell Health provides value-based kidney care, partnering with health plans, payers, and nephrology practices to support patients through nurses and dietitians and improve patient outcomes. It works to lower total cost of care and offers educational resources for patients and industry insights for providers and payers.

1 investor

Intonate offers an AI-powered medical documentation tool that converts consultations, dictations, and documents into structured reports and patient records, integrating directly with practice and clinic management software. It serves doctors, medical practices, and clinics, with a focus on compliance with Swiss and European data protection laws.

1 investor

Intracare Health Services is a licensed, insured, and nationally accredited health services provider. This page is a careers/recruitment page inviting professionals to apply to join the team.

1 investor

A biopharmaceutical company developing treatments for psychiatric and neurologic disorders based on research into how therapies affect cellular mechanisms. The company, now part of Johnson & Johnson, focuses on innovative therapies for patients with complex brain-related diseases.

1 investor

Intrepid Phoenix builds an AI-powered "Quality of Sobriety" app that predicts relapses in people with substance use disorder, enabling clinicians and support networks to intervene before setbacks occur. It serves both patients in recovery and treatment providers, offering personalized recovery plans, progress tracking, and objective recovery data that integrates into existing care plans.

1 investor

Intressa Vascular develops the Allay Aortic Stent using proprietary multilayer braiding technology and personalized procedure planning to treat aortic dissections in patients requiring endovascular intervention.

1 investor

Intus Bio develops Titan-1, a microbiome analysis technology that combines long-read sequencing, patented science, and AI to produce higher-resolution microbiome data than shotgun metagenomic and 16S approaches. It applies these insights to biomarker discovery, drug development, and patient testing across healthcare.

1 investor

Inuka provides digital mental health coaching, connecting people with trained coaches to support wellbeing. Its team is distributed globally and organized around a coaching business and a foundation.

1 investor

Invea Therapeutics is a biotechnology company developing oral small molecule therapies for immune-mediated inflammatory diseases (IMIDs), using artificial intelligence and machine learning to study inflammation mechanisms such as mast cell and inflammasome biology. It targets both common and rare IMIDs to serve patients with chronic inflammatory conditions.

1 investor

InvenireX advances molecular diagnostics in life sciences through innovation in biotechnology. The company develops solutions for scientific research and healthcare applications.

1 investor

Invoke develops personalized cancer treatments using computational biology to predict neoantigens with greater accuracy by modeling individual tumor evolution and immune dynamics. The company serves cancer patients through neoantigen prediction models designed for treatment personalization.

1 investor

Invoy offers a breath-based metabolic testing tool that provides real-time, non-invasive metabolic data to help individuals and communities prevent chronic disease and change health behavior. It is positioned for public health leaders as a scalable approach to earlier intervention and lower long-term healthcare costs.

1 investor

IO Health is an intelligence layer that integrates into existing EMR systems for home health and hospice agencies, providing real-time clinical documentation guidance at point of care, automated QA prioritization, and operational visibility. The platform reduces QA workload and improves documentation accuracy without requiring new systems, logins, or workflow disruption.

1 investor

IOMED is a data space platform that uses AI and natural language processing to extract and structure clinical data from hospital text sources, turning it into research-ready real-world data. It serves hospitals and life science companies seeking secure, compliant access to real-world clinical data for research, operating across an EU5 hospital partner network harmonized under the OMOP Common Data Model.

1 investor

Iona Mind develops low-intensity cognitive behavioral therapy (CBT) digital health products for behavioral and mental health management. The company specializes in customizable, evidence-based platforms that enable patients to access psychological support at their own pace with 24/7 care team support.

1 investor

LeanTaaS provides software that helps hospitals and health systems improve utilization of operating rooms and other clinical capacity. Its offering is aimed at healthcare providers, with reported outcomes such as increased OR prime time utilization.

1 investor

iRen develops medical technology for dialysis patients, enabling them to continue daily activities while undergoing treatment. The company aims to reduce the burden of dialysis on quality of life for people with kidney disease.

1 investor

Iris Telehealth provides telepsychiatry and behavioral health services to health systems, hospitals, and community clinics through a medical group of psychiatrists, LCSWs, and PMHNPs. The Joint Commission-accredited company supports partner organizations in delivering psychiatric care across all ages, acuity levels, and diagnoses in the United States.

1 investor

Ironleap builds AI products for healthcare businesses, mapping clinical and operational workflows to identify automation opportunities, assess compliance and data risks, and deliver tailored AI solutions. It serves healthcare operations teams aiming to improve efficiency, reduce costs, and enhance patient outcomes.

1 investor

Isabl develops genomic sequencing technology for cancer diagnosis, enabling whole genome and transcriptome testing in clinically relevant timeframes to provide comprehensive treatment options. The platform serves physicians and cancer patients globally by making advanced molecular diagnostics accessible.

1 investor

Isabl develops whole genome and transcriptome sequencing technology for cancer diagnosis, delivering comprehensive genomic profiling and treatment options to physicians and research teams. The company provides rapid cancer diagnostic tests in clinically relevant timeframes to improve outcomes for cancer patients globally.

1 investor

iScribe builds an EHR-integrated mobile platform with AI-assisted clinical documentation and E&M coding tools for specialty medical practices such as orthopedics and urology. Its products include iScribe AI for automated note generation, iScribe Code Intelligence for coding accuracy and denial mitigation, and iScribe Flex for independent providers.

1 investor

Isha Health provides ketamine therapy, a treatment for depression and anxiety using oral ketamine administered at home under medical supervision. The service is designed for individuals with treatment-resistant symptoms who seek rapid relief through this dissociative anesthetic approach.

1 investor